文献速递临床试验与 GCP流行病学与生物统计

通过非回避诱导耐受预防持续性食物过敏(TINA)在花生或树坚果过敏儿童和成人中的研究:一项随机对照试验和观察性队列研究的原理、研究设计与方法

Tolerance induction through non-avoidance to prevent persistent food allergy (TINA) in children and adults with peanut or tree nut allergy: rationale, study design and methods of a randomized controlled trial and observational cohort study.
PubMed 文献 · Trials · 2022-03-28

TINA试验包括两部分:一项随机对照开放平行组单中心优效性试验,纳入120例可耐受≥100 mg食物蛋白的花生或树坚果过敏患者,随机分为低剂量花生/树坚果产品规律摄入组或严格回避组,为期1年,主要终点为经口服食物激发试验评估的临床耐受;以及一项前瞻性观察性探索性队列研究,纳入120例致敏但耐受者,建议规律摄入并观察1年,主要终点为维持临床耐受。

要点

  • 花生或树坚果过敏患者当前建议严格回避,但致敏无过敏症状者应经常摄入以预防过敏发生。
  • RCT纳入可耐受≥100 mg食物蛋白的120例患者,比较低剂量摄入与严格回避1年后的临床耐受。
  • 队列研究纳入120例致敏但耐受者,建议规律摄入并观察1年,评估临床耐受维持情况。

核心结论

  • 该临床试验将有助于确定过敏原摄入与回避对自然耐受发展的影响,以及当前针对花生或树坚果过敏且阈值较高患者的饮食建议是否仍然有效。

研究设计与样本

  • TINA试验由两部分组成:第一部分为随机、对照、开放、平行组、单中心、优效性试验(RCT);第二部分为前瞻性观察性探索性队列研究。
  • 研究对象为年龄1-67岁、疑似或已知原发性花生和/或树坚果过敏的儿童和成人,均接受口服食物激发试验以确定临床反应性和个体阈值。
  • RCT纳入120例可耐受≥100 mg食物蛋白的花生或树坚果过敏患者,按1:1比例随机分配至规律摄入含少量花生或树坚果的产品组或严格回避组,为期1年。
  • 队列研究纳入120例对花生和/或树坚果致敏但耐受的受试者,建议规律摄入该食物并观察1年。

主要发现

  • RCT中摄入组从个体阈值的1/100开始,分别在4个月和8个月后增加至1/50和1/10。
  • RCT主要终点为1年后经口服食物激发试验评估的对花生或树坚果的临床耐受。
  • 队列研究主要终点为1年后经 former 耐受累积剂量激发评估的对花生和/或树坚果临床耐受的维持。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Peanuts (PN) and tree nuts (TN) are among the most frequent elicitors of food allergy and can lead to life-threatening reactions. The current advice for allergic patients is to strictly avoid the offending food independently of their individual threshold level, whereas sensitized patients without allergic symptoms should frequently consume the food to avoid (re-)development of food allergy. The aim of this trial is to investigate (I) whether the consumption of low allergen amounts below the individual threshold may support natural tolerance development and (II) to what extent regular allergen consumption in sensitized but tolerant subjects prevents the (re-)development of PN or TN allergy. METHODS: The TINA trial consisting of (part I) a randomized, controlled, open, parallel group, single-center, superiority trial (RCT), and (part II) a prospective observational exploratory cohort study. Children and adults (age 1-67 years) with suspected or known primary PN and/or TN allergy will undergo an oral food challenge (OFC) to determine their clinical reactivity and individual threshold. In the RCT, 120 PN or TN allergic patients who tolerate ≥100 mg of food protein will be randomized (1:1 ratio) to consumption of products with low amounts of PN or TN on a regular basis or strict avoidance for 1 year. The consumption group will start with 1/100 of their individual threshold, increasing the protein amount to 1/50 and 1/10 after 4 and 8 months, respectively. The primary endpoint is the clinical tolerance to PN or TN after 1 year assessed by OFC. In the cohort study, 120 subjects sensitized to PN and/or TN but tolerant are advised to regularly consume the food and observed for 1 year. The primary endpoint is the maintenance of clinical tolerance to PN and/or TN after 1 year assessed by challenging with the former tolerated cumulative dose. DISCUSSION: This clinical trial will help to determine the impact of allergen consumption versus avoidance on natural tolerance development and whether the current dietary advice for PN or TN allergic patients with higher threshold levels is still valid. TRIAL REGISTRATION: German Clinical Trials Register; ID: DRKS00016764 (RCT), DRKS00020467 (cohort study). Registered on 15 January 2020, http://www.drks.de .

来源:Trials,查看原文。版权归原作者所有。

引用

  1. Trendelenburg V, Dölle-Bierke S, Unterleider N, et al. Tolerance induction through non-avoidance to prevent persistent food allergy (TINA) in children and adults with peanut or tree nut allergy: rationale, study design and methods of a randomized controlled trial and observational cohort study. Trials. 2022. PMID: 35346330. doi:10.1186/s13063-022-06149-4

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。